Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
University Hospital Tuebingen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
West China Hospital
West China Hospital
National Institutes of Health Clinical Center (CC)
Fudan University
M.D. Anderson Cancer Center
University College Cork
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Sun Yat-sen University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of Nebraska
Dana-Farber Cancer Institute